March 26, 2025
Stock Brokers

Stocks that moved the most on February 17


It was a day of rebound for benchmark indices Nifty 50 and Sensex on February 17, with both of them closing higher.

At closing, Sensex stood at 75,996.86, higher by 57.65 points while Nifty 50 was at 22,959.50, a gain of 30.25 points as despite concerns of outflow and weak corporate earnings persisting. The BSE Midcap index too saw a smart recovery, while BSE Smallcap continue to see selling pressure.

GAINERS

Bank Nifty reversed its earlier losses on February 17, closing in the green after a nearly 600-point recovery from its intraday low, reaching 49,209. IndusInd Bank led the recovery, gaining over 2 percent and HDFC Bank's near 1 percent rise significantly contributed to the index's upward movement. IDFC First Bank and Punjab National Bank (PNB) also saw gains of 1 percent and 0.44 percent, respectively. State Bank of India (SBI) recorded a smaller gain of 0.4 percent, but its substantial weight in the index provided a positive push. Bank Nifty reversed its earlier losses on February 17, closing in the green after a near 600-point recovery from lows, reaching 49,209. IndusInd Bank led the rebound on the index, gaining over 2 percent and HDFC Bank’s near 1 percent rise significantly contributed to gains. IDFC First Bank and Punjab National Bank (PNB) also carved out gains of 1 percent and 0.44 percent, respectively. State Bank of India (SBI) recorded a smaller gain of 0.4 percent, but its substantial weight in the index provided a positive push.

Godfrey Phillips: Godfrey Phillips shares surged 20 percent, extending a two-day rally to 44 percent, driven by a 49 percent year-on-year increase in Q3 net profit to Rs 316 crore. Over this session and the past session, the stock has soared 36 percent in trade.  Godfrey Phillips: Godfrey Phillips shares surged 20 percent, extending a two-day rally, driven by a 49 percent year-on-year increase in Q3FY25 net profit at Rs 316 crore. Between two sessions, the stock has soared 36 percent in trade.

 

GSK Pharma: GSK Pharma shares gained 20 percent to hit its upper circuit as the firm’s earnings show for the quarter ended December topped estimates on robust volume growth and continued scale-up in vaccine offtake. Brokerages reaffirmed their bullish ratings on the pharma player. GSK Pharma: GSK Pharma shares gained 20 percent to hit its upper circuit as the December quarter earnings topped estimates on robust volume growth and continued scale-up in vaccine offtake. Brokerages reaffirmed their bullish ratings on the pharma player.

Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Ltd shares rose 4 percent following strong FY26 guidance and a return to profitability in Q3FY25. Herein, it reported a net profit of Rs 348 crore compared to a Rs 351 crore loss in the same quarter last year. Glenmark Pharmaceuticals: Shares of Glenmark Pharmaceuticals rose 4 percent following strong FY26 guidance and a return to profitability in Q3FY25. It reported a net profit of Rs 348 crore compared to a Rs 351 crore loss in the same quarter last year.

 

Dilip Buildcon: Dilip Buildcon shares rose 4.4 percent on February 17, 2025, despite mixed Q3 results showing a 7.4 percent rise year-on-year. Its net profit increased to Rs 115.3 crore, but a 9.98 percent decline in revenue to Rs 2,589.7 crore. Dilip Buildcon: Dilip Buildcon shares rose 4.4 percent on February 17, 2025 despite mixed Q3 results, showing a 7.4 percent rise year-on-year. Its net profit increased to Rs 115.3 crore, but the revenue fell by 9.98 percent to Rs 2,589.7 crore.

 

LOSERS

Zen Technologies: Shares of Zen Technologies plunged 20 percent due to a sequential decline in Q3 net profit. Its net profit nearly halved to Rs 38.62 crore from Rs 65.24 crore in the previous quarter, despite a year-on-year increase. Zen Technologies: Shares of Zen Technologies plunged 20 percent due to a sequential decline in Q3FY25 net profit. The profit nearly halved to Rs 38.62 crore from Rs 65.24 crore in the previous quarter, despite a year-on-year increase.

Samvardhana Motherson: Samvardhana Motherson shares fell over 3 percent after brokerages, including JPMorgan and Jefferies, lowered price targets on the firm due to a soft near-term global outlook for the auto component sector, despite Q3 results being in line with estimates. Samvardhana Motherson: Samvardhana Motherson shares fell over 3 percent after brokerages, including JPMorgan and Jefferies, lowered price targets due to a soft near-term global outlook for the auto component sector, despite Q3FY25 results being in line with estimates.

Rail Vikas Nigam Ltd (RVNL): RVNL shares decreased by 7 percent following the release of Q3FY25 results, which showed a net profit of Rs 311 crore, a 13 percent drop from the Rs 359 crore reported in Q3FY24. Rail Vikas Nigam Ltd (RVNL): RVNL shares decreased by 7 percent following the release of Q3FY25 results, which showed a net profit of Rs 311 crore, a 13 percent drop from the Rs 359 crore reported in Q3FY24.

Concord Biotech: Concord Biotech shares fell by nearly 12 percent in reaction to Q3FY25 earnings. The firm reported a net profit of Rs 76 crore, a 2 percent year-on-year decrease from Rs 78 crore, alongside a decrease in revenue. Concord Biotech: Concord Biotech shares fell by nearly 12 percent in reaction to Q3FY25 earnings. The firm reported a net profit of Rs 76 crore, a 2 percent year-on-year decrease from Rs 78 crore, alongside a decrease in revenue.

Genesys International Corporation: Genesys International Corporation shares extended losses over three sessions, dropping over 14 percent today, marking a six-month low. This comes despite the release of Q3FY25 results, which showed that profit rose 30 percent on-year. Genesys International Corporation: Genesys International shares extended losses over three sessions, dropping over 14 percent, marking a six-month low. This comes despite Q3FY25 results showing a 30 percent on-year rise in net profit. 



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *